ResMed (RMD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
26 Oct, 2026Executive summary
Annual meeting scheduled for Nov. 19, 2025, at 3:00 p.m. US Pacific Time / Nov. 20 at 10:00 a.m. Australian Eastern Time, via live webcast.
Shareholders can vote on director elections, auditor ratification, advisory executive compensation, and amendments to two employee equity plans.
Voting matters and shareholder proposals
Board recommends voting for all five agenda items: 11 director nominees, KPMG LLP ratification, advisory executive compensation, and amendments to the 2009 Incentive Award Plan and 2018 Employee Stock Purchase Plan.
Board of directors and corporate governance
11 directors nominated for election, each to serve until the 2026 annual meeting and until a successor is elected and qualified: Carol Burt, Christopher DelOrefice, Jan De Witte, Karen Drexler, Michael Farrell, Peter Farrell, Harjit Gill, John Hernandez, Nicole Mowad-Nassar, Desney Tan, and Ronald Taylor.
Latest events from ResMed
- Revenue rose 7% core CC, EPS 14%, and shareholder returns topped $1.0B.RMD
Q1 2027 - Shareholders were asked to elect 10 directors, ratify KPMG, and approve executive pay.RMDProxy Filing
- Ten director elections, KPMG ratification, and advisory votes anchor the ballot.RMDProxy Filing
- Board backs all three proposals: elect 11 directors, ratify KPMG and approve say-on-pay.RMDProxy Filing
- 2026 saw strong growth, strategic investments, and enhanced sustainability and governance.RMDStewardship presentation
- FY26 saw 8% revenue growth, 16% EPS growth, and $1B returned to shareholders.RMDCorporate presentation
- Volume-driven growth, digital engagement, and portfolio shifts drive robust outlook.RMDMorgan Stanley 24th Annual Global Healthcare Conference
- FY26 revenue grew 8% to $5.7B, with strong margins, digital innovation, and increased shareholder returns.RMDCorporate presentation
- Record FY26 growth, margin expansion, and $1.85B+ FY27 capital returns planned.RMDQ4 2026